文献速递免疫规划职业卫生

接种一剂BNT162b2 mRNA新冠疫苗后感染SARS-CoV-2的免疫应答:一项意大利前瞻性观察性研究

Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study.
PubMed 文献 · Vaccine · 2022-02-16

该研究在意大利巴里综合医院对100名医护人员进行两臂观察性队列分析,比较接种一剂BNT162b2 mRNA疫苗后感染SARS-CoV-2者(感染组25人)与完成两剂接种者(疫苗组75人)的抗体应答。血清学评估显示全部受试者阳性,总几何平均滴度为7106.8(95%CI=5628.5-8973.4),感染组GMT为2139.7(95%CI=1310.4-3493.6),疫苗组为10603.6(95%CI=8698.0-12926.8),两组差异有统计学意义(p<0.0001)。

要点

  • 100名医护人员中感染组25人(25.0%),全程疫苗组75人(75.0%)。
  • 总GMT为7106.8(95%CI=5628.5-8973.4),所有受试者血清学阳性。
  • 感染组GMT为2139.7,低于疫苗组GMT 10603.6,差异有统计学意义(p<0.0001)。

核心结论

  • 接种一剂BNT162b2 mRNA疫苗后感染SARS-CoV-2的医护人员抗体几何平均滴度低于完成两剂接种者,两组差异有统计学意义(p<0.0001)。
  • 作者强调医护人员在两剂抗SARS-CoV-2疫苗接种之间的窗口期需继续使用个人防护装备(PPE)并保持良好实践。

研究设计与样本

  • 两臂观察性队列研究,利用意大利巴里综合医院(Bari Policlinico General Hospital)医护人员常规健康监测数据。
  • 共纳入100名医护人员,感染组25人(25.0%),全程疫苗组75人(75.0%)。

主要发现

  • 血清学评估时所有医护人员均为阳性,总几何平均滴度(GMT)为7106.8(95%CI=5628.5-8973.4)。
  • 感染组GMT为2139.7(95%CI=1310.4-3493.6),疫苗组GMT为10603.6(95%CI=8698.0-12926.8)。
  • 感染组与疫苗组GMT差异有统计学意义(p<0.0001)。

临床怎么用

  • 作者强调医护人员在两剂抗SARS-CoV-2疫苗接种之间的窗口期需继续使用个人防护装备(PPE)并保持良好实践。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A mass vaccination campaign against SARS-CoV-2 was initiated in European countries on December 27, 2020. This study compared the antibody response in a sample of healthcare workers (HCWs) who, after the first dose of the BNT162b2 mRNA vaccine, were infected with SARS-CoV-2 (infection group) with the response in a control group of HCWs immunized with two doses (vaccine group). METHODS: This two-arm observational cohort study was carried out using routine health surveillance data obtained from HCWs at Bari Policlinico General Hospital (Italy). The antibody response was determined infection group and vaccine group. RESULTS: Among the 100 HCWs, 25 (25.0%) were in the infection group and 75 (75.0%) in the full-vaccine group. At the serological evaluation, all of the HCWs tested positive, with a geometric mean titer (GMT) of 7106.8 (95 %CI = 5628.5-8973.4) and a statistically significant difference (p < 0.0001) between the infection group (GMT = 2139.7; 95 %CI = 1310.4-3493.6) and the vaccine group (GMT = 10603.6; 95 %CI = 8698.0-12926.8). DISCUSSION: Our results shed light on the vaccine response of individuals in different risk categories. It also emphasizes the need for the continued use by HCWs of PPE and good practices during the window between the first and second anti-SARS-CoV-2 vaccinations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Stefanizzi P, Larocca AMV, Martinelli A, et al. Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study. Vaccine. 2022. PMID: 35190212. doi:10.1016/j.vaccine.2022.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。